Increasing Sodium-Glucose Cotransporter 2 Inhibitor Use in CKD: Perspectives and Presentation of a Clinical Pathway

Kidney Med. 2022 Mar 12;4(5):100446. doi: 10.1016/j.xkme.2022.100446. eCollection 2022 May.

Authors

Laura Nishi¹, Cybele Ghossein², Anand Srivastava^{2

3}

Affiliations

¹ Department of Nephrology and Hypertension, Northwestern Medicine, Chicago, Illinois.
² Division of Nephrology and Hypertension, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
³ Center for Translational Metabolism and Health, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

No abstract available

Publication types

Editorial